-
Tencent mobilizes swift response after QQ data hijacked
Jul 3, 2022
Tencent said on Monday the company is collecting criminal evidence after a large number of users reported their QQ numbers were stolen and used to send advertisements to their friends on the instant messaging service.
-
JD, Tencent extend strategic partnership
Jul 3, 2022
Chinese e-commerce giant JD said in an announcement on the Hong Kong Stock Exchange that it has extended strategic partnership agreement with tech heavyweight Tencent Holdings Ltd for a period of three years.
-
China's internet sector reports steady revenue growth in first 5 months
Jul 3, 2022
China's internet sector saw steady growth in business revenue in the first five months of the year, data from the Ministry of Industry and Information Technology showed.
-
Lenovo launches its first in-house plant in Europe
Jun 19, 2022
Chinese tech heavyweight Lenovo Group Ltd is expanding its global manufacturing footprint with a new factory in Ullo, Hungary.
-
Didi on OTC bourse after delisting from NYSE
Jun 19, 2022
Chinese ride-hailing company Didi Global Inc was set to start trading its shares on the over-the-counter market on Monday, after delisting from the New York Stock Exchange on Friday and pending a China cybersecurity review-prerequisites for its business to resume normal operations.
-
Cainiao opens China-US sea freight service
Jun 19, 2022
Cainiao Network has introduced an international logistics service promising "port-to-warehouse" delivery between China and the United States within 30 days, the latest move to facilitate cross-border transportation and bolster exports by Chinese merchants.
-
JD's appetite for ready meals biz grows
Jun 10, 2022
Chinese e-commerce giant JD Inc is betting big on the fast-growing ready-to-cook, ready-to-heat and ready-to-eat meals segment, which has gained popularity among younger Chinese consumers since the outbreak of the COVID-19 pandemic.
-
BeiGene cancer drug receives further international approval
Jun 10, 2022
Chinese biotech enterprise BeiGene announced on Monday that its cancer treatment Brukinsa (zanubrutinib) has been approved by authorities in Kuwait, Bahrain and Qatar for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.